SAMDaily.us | MOD | 65 | Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody

SAMDAILY.US - ISSUE OF OCTOBER 11, 2024 SAM #8354
MODIFICATION

65 -- Good Manufacturing Practice (GMP)-manufactured Monoclonal Antibody

Notice Date: 10/9/2024 7:21:34 AM
Notice Type: Justification
NAICS: 325412 — Pharmaceutical Preparation Manufacturing
Contracting Office: NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
ZIP Code: 20892
Solicitation Number: JA-NIAID-24-2226773
Archive Date: 11/08/2024
Point of Contact: Hershea Vance, Phone: 3017616404, Linda Smith
E-Mail Address: hershea.vance@nih.gov, linda.smith2@nih.gov
(hershea.vance@nih.gov, linda.smith2@nih.gov)
Award Number: 75N93024P01131
Award Date: 09/27/2024
Description: United BioPharma, is the patent holder and manufacturer for UB-421, and the�only company that possesses the cell line necessary for its production. As such,�United BioPharma is the only known source to produce this drug. Justification document attached.�
Web Link: SAM.gov Permalink
(https://sam.gov/opp/72a563278ca94cf4b3b5c5edb1fe3ce2/view)
Place of Performance: Address: Bethesda, MD 20817, USA; Zip Code: 20817; Country: USA
Record: SN07236772-F 20241011/241009230059 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |